Cypress Capital Group Novartis Ag Transaction History

Cypress Capital Group

$783 Million
Q2 2025

A detailed history of Cypress Capital Group transactions in Novartis Ag stock. As of the latest transaction made, Cypress Capital Group holds 5,776 shares of NVS stock, worth $764,684. This represents 0.09% of its overall portfolio holdings.

Number of Shares

5,776

Previous 3,138 84.07%

Holding current value

$764,684

Previous $349,000 100.0%

% of portfolio

0.09%

Previous 0.05%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 25, 2025	BUY	$101.96 - $121.01 $268,970 - $319,224	2,638 Added 84.07%	5,776 $698,000
Q1 2025 May 12, 2025	SELL	$97.14 - $115.57 $1,942 - $2,311	-20 Reduced 0.63%	3,138 $349,000
Q4 2024 Feb 06, 2025	SELL	$96.78 - $117.18 $29,034 - $35,154	-300 Reduced 8.68%	3,158 $307,000
Q3 2024 Nov 08, 2024	BUY	$106.13 - $120.89 $4,139 - $4,714	39 Added 1.14%	3,458 $397,000
Q2 2024 Jul 25, 2024	SELL	$92.57 - $107.37 $35,176 - $40,800	-380 Reduced 10.0%	3,419 $363,000
Q1 2024 May 08, 2024	SELL	$95.27 - $108.47 $10,003 - $11,389	-105 Reduced 2.69%	3,799 $367,000
Q4 2023 Jan 24, 2024	SELL	$92.27 - $101.54 $21,314 - $23,455	-231 Reduced 5.59%	3,904 $394,000
Q3 2023 Nov 02, 2023	SELL	$94.73 - $105.13 $14,398 - $15,979	-152 Reduced 3.55%	4,135 $421,000
Q2 2023 Jul 26, 2023	SELL	$92.52 - $104.91 $6,568 - $7,448	-71 Reduced 1.63%	4,287 $432,000
Q1 2023 May 04, 2023	SELL	$80.03 - $92.81 $800 - $928	-10 Reduced 0.23%	4,358 $400,000
Q4 2022 Feb 14, 2023	SELL	$75.55 - $92.52 $982 - $1,202	-13 Reduced 0.3%	4,368 $396,000
Q3 2022 Nov 04, 2022	SELL	$74.61 - $87.26 $4,103 - $4,799	-55 Reduced 1.24%	4,381 $333,000
Q2 2022 Jul 26, 2022	SELL	$80.52 - $93.75 $2,415 - $2,812	-30 Reduced 0.67%	4,436 $375,000
Q1 2022 May 16, 2022	SELL	$80.11 - $90.62 $54,154 - $61,259	-676 Reduced 13.15%	4,466 $392,000
Q4 2021 Feb 15, 2022	BUY	$79.7 - $88.13 $5,260 - $5,816	66 Added 1.3%	5,142 $450,000
Q3 2021 Oct 12, 2021	BUY	$81.78 - $95.14 $13,003 - $15,127	159 Added 3.23%	5,076 $415,000
Q1 2021 Apr 14, 2021	SELL	$83.5 - $98.47 $417 - $492	-5 Reduced 0.1%	4,917 $420,000
Q4 2020 Jan 12, 2021	SELL	$78.07 - $94.43 $29,432 - $35,600	-377 Reduced 7.11%	4,922 $464,000
Q3 2020 Oct 08, 2020	BUY	$82.14 - $91.0 $49,366 - $54,691	601 Added 12.79%	5,299 $461,000
Q2 2020 Jul 10, 2020	BUY	$80.93 - $91.1 $25,088 - $28,241	310 Added 7.06%	4,698 $411,000
Q1 2020 Apr 08, 2020	BUY	$70.67 - $99.01 $11,024 - $15,445	156 Added 3.69%	4,388 $362,000
Q4 2019 Jan 10, 2020	SELL	$84.35 - $95.37 $843 - $953	-10 Reduced 0.24%	4,232 $401,000
Q3 2019 Oct 10, 2019	BUY	$85.54 - $94.26 $9,751 - $10,745	114 Added 2.76%	4,242 $369,000
Q2 2019 Aug 15, 2019	BUY	$75.4 - $92.8 $30,160 - $37,120	400 Added 10.73%	4,128 $377,000
Q1 2019 May 14, 2019	BUY	$75.32 - $86.15 $28,847 - $32,995	383 Added 11.45%	3,728 $358,000
Q4 2018 Feb 19, 2019	BUY	$73.66 - $82.02 $22,834 - $25,426	310 Added 10.21%	3,345 $287,000
Q3 2018 Nov 15, 2018	BUY	$66.94 - $77.43 $203,162 - $235,000	3,035 New	3,035 $261,000

Others Institutions Holding NVS

# of Institutions

1,562

Shares Held

136M

Call Options Held

1.72M

Put Options Held

1.7M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $285B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cypress Capital Group, based on Form 13F filings with the SEC.

News

Stay updated on Cypress Capital Group with notifications on news.

Account

Cypress Capital Group Novartis Ag Transaction History